Lawmakers Advance Bipartisan Solutions to Hold Big Pharma Accountable for… Read More
U.S. House Judiciary Subcommittee Hearing Builds Bipartisan Momentum for ETHIC… Read More
Health Care Leaders and Policy Experts Agree Bipartisan, Market-Based… Read More
Big Pharma Hides Behind False Innovation Rhetoric to Maintain Rampant Abuse of… Read More
Analysis Details How Big Pharma’s Patent Abuse Delays Generic and Biosimilar… Read More
Bipartisan Letter Targets Big Pharma’s Misleading Ads That Inflate Costs And… Read More
Administration Touts Positive Steps to Bring More Biosimilars to Market… Read More
U.S. House Energy & Commerce Health Subcommittee Hearing Puts Big Pharma… Read More
Lawmaker Highlights Broad-Based Support for Bipartisan Solution to Disclose… Read More
Members of Congress Say Addressing “Patent Thickets Surrounding Branded… Read More
HHS, FDA and CMS Leaders Emphasize How Streamlining Biosimilar Approvals Will… Read More
U.S. House Committee on Energy and Commerce Advances Bipartisan… Read More